These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 11896748)
21. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo. Shenouda NS; Sakla MS; Newton LG; Besch-Williford C; Greenberg NM; MacDonald RS; Lubahn DB Endocrine; 2007 Feb; 31(1):72-81. PubMed ID: 17709901 [TBL] [Abstract][Full Text] [Related]
22. [Effect of raveron and levorin on urination recovery in prostatic adenoma and chronic prostatitis]. Savin VF; Antonov NM; Arkannikov AB Urol Nefrol (Mosk); 1982; (2):22-4. PubMed ID: 6177084 [No Abstract] [Full Text] [Related]
23. [New ways of conservative treatment of bladder neck diseases]. Massier J Wien Klin Wochenschr; 1971 May; 83(19):337-8. PubMed ID: 4104107 [No Abstract] [Full Text] [Related]
24. Phenoxybenzamine for symptoms of bladder neck obstruction. Drug Ther Bull; 1983 Feb; 21(4):15-6. PubMed ID: 6187524 [No Abstract] [Full Text] [Related]
25. Review of the experience and evidence of Pygeum africanum in urological practice. Salinas-Casado J; Esteban-Fuertes M; Carballido-RodrÃguez J; Cozar-Olmo JM Actas Urol Esp (Engl Ed); 2020; 44(1):9-13. PubMed ID: 31627963 [TBL] [Abstract][Full Text] [Related]
26. [Clinical effect of the drug "Prostamol-Uno" in patients with benign prostatic hyperplasia and chronic prostatitis]. Mazo EB; Dmitriev DG Urologiia; 2001; (5):38-41. PubMed ID: 11641979 [No Abstract] [Full Text] [Related]
27. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia]. Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514 [No Abstract] [Full Text] [Related]
28. [Standardized extract of Pygeum africanum in the treatment of benign prostatic hypertrophy. Controlled clinical study versus placebo]. Bassi P; Artibani W; De Luca V; Zattoni F; Lembo A Minerva Urol Nefrol; 1987; 39(1):45-50. PubMed ID: 2441479 [No Abstract] [Full Text] [Related]
29. Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health. Thompson RQ; Katz D; Sheehan B J Pharm Biomed Anal; 2019 Jan; 163():162-169. PubMed ID: 30316061 [TBL] [Abstract][Full Text] [Related]
30. [Therapy of the neurogenic bladder and of the prostatitis syndrome using Nomon]. Faris F Munch Med Wochenschr; 1972 Jan; 114(4):153-4. PubMed ID: 5066868 [No Abstract] [Full Text] [Related]
31. Male lower urinary tract symptoms and sildenafil. Jackson G Int J Clin Pract; 2007 Nov; 61(11):1779. PubMed ID: 17935539 [No Abstract] [Full Text] [Related]
32. Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis. Steenkamp V; Gouws MC; Gulumian M; Elgorashi EE; van Staden J J Ethnopharmacol; 2006 Jan; 103(1):71-5. PubMed ID: 16122891 [TBL] [Abstract][Full Text] [Related]
34. Getting ready for certification: urinary tract inflammation and disease. Linn MM Urol Nurs; 2007 Aug; 27(4):324-5. PubMed ID: 17877104 [No Abstract] [Full Text] [Related]
35. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms. Lemack GE Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351 [No Abstract] [Full Text] [Related]
36. [Use of "Ubretid" in the field of urology]. Inada T; Ebisuta K; Harada T Hinyokika Kiyo; 1967 May; 13(5):429-32. PubMed ID: 4169450 [No Abstract] [Full Text] [Related]
37. Effect of oral Tadenan treatment on rabbit bladder structure and function after partial outlet obstruction. Levin RM; Hass MA; Bellamy F; Horan P; Whitbeck K; Chow PH; Kung LS; Gosling J J Urol; 2002 May; 167(5):2253-9. PubMed ID: 11956488 [TBL] [Abstract][Full Text] [Related]
38. The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries. Hutchison A; Farmer R; Verhamme K; Berges R; Navarrete RV Eur Urol; 2007 Jan; 51(1):207-15; discussion 215-6. PubMed ID: 16846678 [TBL] [Abstract][Full Text] [Related]
39. Clinical management of lower urinary tract symptoms with combined medical therapy. Roehrborn CG BJU Int; 2008 Nov; 102 Suppl 2():13-7. PubMed ID: 19032605 [No Abstract] [Full Text] [Related]